Fig. 2

Immunohistochemical expression of Fork head transcription factor (FOXP-1); (a) High nuclear FOXP-1 expression in DLBCL stage IV × 400 (b) High nuclear FOXP1 expression in DLBCL stage III × 400 (c) negative nuclear FOXP-1 expression in DLBCL stage I × 400. (d) Positive nuclear FOXP-1 expression in sections from squamous cell carcinoma of the cervix as appositive control of the marker × 400 (e) Negative control by replacement of the primary anti-FOXP-1 antibody by phosphate buffered saline × 400